東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Protein targeting compounds = predic...

Boldicke, Thomas.

Linked to FindBook

Google Book

Amazon

博客來

Protein targeting compounds = prediction, selection and activity of specific inhibitors /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Protein targeting compounds/ edited by Thomas Boldicke.
Reminder of title:	prediction, selection and activity of specific inhibitors /
other author:	Boldicke, Thomas.
Published:	Cham :Springer International Publishing : : 2016.,
Description:	viii, 288 p. :ill., digital ;24 cm.
[NT 15003449]:	Introduction -- Part I Methods of Structure Prediction -- Chapter 1 In Silico Prediction of Target-Inhibitor Interactions -- Part II Antibodies -- Chapter 2 Antibodies and Selection of Monoclonal Antibodies -- Chapter 3 Selection of Recombinant Human Antibodies -- Chapter 4 Selection of Recombinant Human Antibodies against Toxins and Viruses -- Chapter 5 Recent Advances with ER Targeted Intrabodies -- Chapter 6 Therapeutic Blocking Antibodies against Oncogenic Receptors and Growth Factors -- Chapter 7 Synthetic Cystine-Knot Miniproteins-Valuable Scaffolds for Polypeptide Engineering -- Part III Peptides, Small Molecules and Aptamers -- Chapter 8 Peptides and Peptide Analogs to Inhibit Protein -- Chapter 9 Allosteric Modulators of the Class A G Protein coupled Receptors -- Chapter 10 Phosphatases: Their Roles in Cancer and their Chemical Modulators -- Chapter 11 Selection and Application of Aptamers and Intramers -- Part IV Angiogenesis Inhibitors -- Chapter 12 Inhibitors of Angiogenesis.
Contained By:	Springer eBooks
Subject:	Proteins - Synthesis -
Online resource:	http://dx.doi.org/10.1007/978-3-319-32805-8
ISBN:	9783319328058

Protein targeting compounds = prediction, selection and activity of specific inhibitors /
Protein targeting compoundsprediction, selection and activity of specific inhibitors /[electronic resource] :edited by Thomas Boldicke. - Cham :Springer International Publishing :2016. - viii, 288 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.9170065-2598 ;. - Advances in experimental medicine and biology ;946..

Introduction -- Part I Methods of Structure Prediction -- Chapter 1 In Silico Prediction of Target-Inhibitor Interactions -- Part II Antibodies -- Chapter 2 Antibodies and Selection of Monoclonal Antibodies -- Chapter 3 Selection of Recombinant Human Antibodies -- Chapter 4 Selection of Recombinant Human Antibodies against Toxins and Viruses -- Chapter 5 Recent Advances with ER Targeted Intrabodies -- Chapter 6 Therapeutic Blocking Antibodies against Oncogenic Receptors and Growth Factors -- Chapter 7 Synthetic Cystine-Knot Miniproteins-Valuable Scaffolds for Polypeptide Engineering -- Part III Peptides, Small Molecules and Aptamers -- Chapter 8 Peptides and Peptide Analogs to Inhibit Protein -- Chapter 9 Allosteric Modulators of the Class A G Protein coupled Receptors -- Chapter 10 Phosphatases: Their Roles in Cancer and their Chemical Modulators -- Chapter 11 Selection and Application of Aptamers and Intramers -- Part IV Angiogenesis Inhibitors -- Chapter 12 Inhibitors of Angiogenesis.

This book presents an overview of the most relevant protein knockdown techniques. Readers will find a description of the generation and use of recombinant human antibodies, ER intrabodies and peptides as well as a description of the working mechanism and potential of the inhibitory action of each of these molecules. The book will also describe the selection and activity of a number of phosphatases, aptamers and allosteric modulators, focusing on A G protein coupled receptors. The book starts with a chapter on the in silico prediction of target-inhibitor interactions. Key aspects of this book are: - Selection strategies for monoclonal and recombinant human antibodies - Selection strategies for ER intrabodies, peptides and aptamers - Examples of the most efficient inhibitors and their applications in protein biochemistry and cell biology - Antibodies for cancer therapy and inhibitors of angiogenesis. The book will be of great interest to scientists and students working in the life sciences on all areas related to protein biology. The variety of methods to modulate the activities of specific proteins which are introduced here will be of great benefit to the reader who is interested in general protein research or to readers who have very specific protein related questions.

ISBN: 9783319328058

Standard No.: 10.1007/978-3-319-32805-8doiSubjects--Topical Terms:

2194686
Proteins
--Synthesis

LC Class. No.: QP551

Dewey Class. No.: 572.645

Protein targeting compounds = prediction, selection and activity of specific inhibitors /
LDR:03352nmm a2200325 a 4500 001 2037857
003 DE-He213
005 20161019141050.0
006 m d
007 cr nn 008maaau
008 161209s2016 gw s 0 eng d
020 $a 9783319328058 $q (electronic bk.)
020 $a 9783319328041 $q (paper)
024 7 $a 10.1007/978-3-319-32805-8 $2 doi
035 $a 978-3-319-32805-8
040 $a GP $c GP
041 0 $a eng
050 4 $a QP551
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 572.645 $2 23
090 $a QP551 $b .P967 2016
245 0 0 $a Protein targeting compounds $h [electronic resource] : $b prediction, selection and activity of specific inhibitors / $c edited by Thomas Boldicke.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a viii, 288 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.917
505 0 $a Introduction -- Part I Methods of Structure Prediction -- Chapter 1 In Silico Prediction of Target-Inhibitor Interactions -- Part II Antibodies -- Chapter 2 Antibodies and Selection of Monoclonal Antibodies -- Chapter 3 Selection of Recombinant Human Antibodies -- Chapter 4 Selection of Recombinant Human Antibodies against Toxins and Viruses -- Chapter 5 Recent Advances with ER Targeted Intrabodies -- Chapter 6 Therapeutic Blocking Antibodies against Oncogenic Receptors and Growth Factors -- Chapter 7 Synthetic Cystine-Knot Miniproteins-Valuable Scaffolds for Polypeptide Engineering -- Part III Peptides, Small Molecules and Aptamers -- Chapter 8 Peptides and Peptide Analogs to Inhibit Protein -- Chapter 9 Allosteric Modulators of the Class A G Protein coupled Receptors -- Chapter 10 Phosphatases: Their Roles in Cancer and their Chemical Modulators -- Chapter 11 Selection and Application of Aptamers and Intramers -- Part IV Angiogenesis Inhibitors -- Chapter 12 Inhibitors of Angiogenesis.
520 $a This book presents an overview of the most relevant protein knockdown techniques. Readers will find a description of the generation and use of recombinant human antibodies, ER intrabodies and peptides as well as a description of the working mechanism and potential of the inhibitory action of each of these molecules. The book will also describe the selection and activity of a number of phosphatases, aptamers and allosteric modulators, focusing on A G protein coupled receptors. The book starts with a chapter on the in silico prediction of target-inhibitor interactions. Key aspects of this book are: - Selection strategies for monoclonal and recombinant human antibodies - Selection strategies for ER intrabodies, peptides and aptamers - Examples of the most efficient inhibitors and their applications in protein biochemistry and cell biology - Antibodies for cancer therapy and inhibitors of angiogenesis. The book will be of great interest to scientists and students working in the life sciences on all areas related to protein biology. The variety of methods to modulate the activities of specific proteins which are introduced here will be of great benefit to the reader who is interested in general protein research or to readers who have very specific protein related questions.
650 0 $a Proteins $x Synthesis $x Inhibitors. $3 2194686
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Immunology. $3 611031
700 1 $a Boldicke, Thomas. $3 2194685
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 1565434
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-32805-8
950 $a Biomedical and Life Sciences (Springer-11642)